Mangoceuticals

MGRX · NASDAQ

$0.30+$0.0199 (+7.10%)TodayMarket closed ·
Prev close $0.2801

Latest news

  • NewsRishabh Mishra

    Stock Market Today: S&P 500, Dow Jones Futures Gain as September Jobs Report Misses Expectations— Nike, Synaptics, Corteva in Focus (UPDATED)

  • NewsAvi Kapoor

    Nike Posts Mixed Q1 Results, Joins Mangoceuticals And Other Big Stocks Moving Lower In Friday’s Pre-Market Session

  • NewsAvi Kapoor

    Nike, Synaptics And 3 Stocks To Watch Heading Into Friday

  • NewsTanya Rawat

    Mangoceuticals (MGRX) Shares Fall 12% After Hours: Here's Why

  • Press releaseGlobe Newswire

    Mangoceuticals Secures $2.5 Million Strategic Investment in MangoRx IP Holdings; Receives Initial $1.75 Million Tranche

  • News

    12 Consumer Staples Stocks Moving In Monday's After-Market Session

  • Press releaseBusiness Wire

    MGRX Stock Alert: Halper Sadeh LLC is Investigating Whether Mangoceuticals, Inc. is Obtaining a Fair Price for its Shareholders

  • News

    12 Consumer Staples Stocks Moving In Thursday's After-Market Session

  • Press releaseGlobe Newswire

    Mangoceuticals Inc.’s Merger Partner, Nuclea Energy, Inc., Enters into Definitive Agreement to Acquire Moltex Energy’s Advanced Nuclear Technology Assets

  • Press releaseNewsfile

    Nuclea Energy, Enters into Definitive Agreement to Acquire Moltex Energy's Advanced Nuclear Technology Assets

  • News

    Mangoceuticals’ Merger Partner Nuclea Energy Signs MoU With New Mining To Study Behind-The-Meter Use Of Modular Reactors To Power High-Density Computing

  • Press releaseNewsfile

    Nuclea Energy Signs MOU with New Mining Co. to Advance Behind-the-Meter Modular Reactor Deployment for High-Density Computing Infrastructure

  • Press releaseGlobe Newswire

    Mangoceuticals’ Merger Partner, Nuclea Energy Inc., Signs MOU with New Mining Co. to Advance Behind-the-Meter Modular Reactor Deployment for High-Density Computing Infrastructure

  • NewsMohd Haider

    Mangoceuticals (MGRX) Stock Jumps Over 49% After Hours: Here's Why

  • Press releaseGlobe Newswire

    Mangoceuticals’ Merger Partner, Nuclea Energy (“Nuclea”), Executes MOU with Utah Office of Energy Development

  • Press releaseNewsfile

    Nuclea Energy USA Inc. Announces MOU with Utah Office of Energy Development

  • Press releaseGlobe Newswire

    Mangoceuticals Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Requirement and Comments on Nuclea Energy Business Combination

  • News

    11 Consumer Staples Stocks Moving In Monday's After-Market Session

  • NewsAvi Kapoor

    Why Atkore Shares Are Trading Higher By 26%; Here Are 20 Stocks Moving Premarket

  • NewsAvi Kapoor

    Nasdaq Surges 300 Points; Amazon Shares Jump Following Upbeat Earnings

  • NewsMohd Haider

    Mangoceuticals (MGRX) Stock Jumps 138% After Hours On Nuclear Reactor Deal: Here's Why It Is Trending

  • News

    12 Consumer Staples Stocks Moving In Monday's Pre-Market Session

  • News

    12 Consumer Staples Stocks Moving In Thursday's Pre-Market Session

  • NewsVandana Singh

    Mangoceuticals Stock Doubles After Texas Lawsuit

  • NewsAvi Kapoor

    Dow Jumps Over 800 Points; Chicago Fed National Activity Index Declines In February

  • NewsAvi Kapoor

    Nasdaq Gains 1%; PPL Posts In-Line Q4 Earnings

  • NewsAvi Kapoor

    Dow Rises Over 100 Points; US GDP Growth Slows In Q4

  • NewsAvi Kapoor

    Nasdaq Surges Over 1%; Lamb Weston Shares Decline Following Q2 Results

  • NewsAvi Kapoor

    Dow Gains Over 200 Points; Conagra Shares Fall After Q2 Results

  • NewsVandana Singh

    Ozempic Maker Novo Nordisk Faces Board Shakeup

  • News

    Market-Moving News for November 13th

  • Press releaseACCESS Newswire

    CEO Spotlight: How Mangoceuticals Inc. is Reinventing The Personal Health Landscape

  • NewsAvi Kapoor

    Top 3 Risk Off Stocks Which Could Rescue Your Portfolio This Quarter

  • News

    12 Consumer Staples Stocks Moving In Tuesday's After-Market Session

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.